PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome

Overview of attention for article published in Frontiers in Pharmacology, August 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 2 news outlets
twitter: 25 X users
patent: 12 patents

wikipedia: 3 Wikipedia pages
video: 1 YouTube creator

Readers on

mendeley: 1562 Mendeley

Summary News X Patents Wikipedia YouTube

So far, Altmetric has seen 2 news stories from 2 outlets.

经过粪便移植后，他们的癌症好转了

sina.com.cn, 20 Feb 2021

癌细胞（扫描电镜成像）。图片来源：University of Basel, Swiss Nanoscience Institute/Biozentrum 抗恶性肿瘤药物（如抗PD-1药物）的出现，是癌症治疗中一道曙光，但就算是其中知名的药物——帕博利珠单抗…

Advanced cutaneous squamous cell carcinoma (CSCC) and the evolving treatment landscape - ecancer

ecancer, 04 Feb 2020

By Monique Biryiana Sponsored by Regeneron and Sanofi. Dr Dirk Schadendorf Director of the Department of Dermatology and the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.